Our Pricing

Mounjaro 5mg Single Pen: Your Complete UK Treatment Guide

Published on: June 03, 2026

When you buy Mounjaro 5mg single pen UK online, you're accessing the most advanced weight loss treatment licensed by the MHRA. For the cheapest buy Mounjaro 5mg single pen UK online, Cured Pharmacy provides genuine UK-licensed Mounjaro pens at £124.99, supported by free clinical consultations with UK prescribers and discreet next-day delivery across the United Kingdom.

How Mounjaro 5mg Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed for weight management in the UK [1]. The 5mg dose serves as the initial maintenance strength after the 2.5mg starter dose, helping your body adjust to the medication's appetite-regulating effects whilst minimising side effects. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously.

This dual mechanism produces more pronounced weight reduction than GLP-1-only medications. In the SURMOUNT-1 trial, participants taking tirzepatide 5mg achieved an average 15.0% body weight reduction over 72 weeks, compared to 2.4% with placebo [1]. The medication works by slowing gastric emptying, reducing appetite signals to the brain, and improving insulin sensitivity — all critical factors in sustainable weight management.

Importantly, 85% of participants on tirzepatide 5mg achieved at least 5% weight loss — the clinical threshold associated with meaningful health improvements — compared to just 35% in the placebo group [1]. Additionally, 50% of the 5mg cohort lost 15% or more of their body weight, a magnitude previously only achievable through bariatric surgery. The trial also demonstrated improvements in cardiometabolic markers including blood pressure, lipid profiles, and inflammatory markers. Those seeking the cheapest buy Mounjaro 5mg single pen UK online can access these results through Cured Pharmacy.

Clinical Evidence: SURMOUNT and SURPASS Trials

The SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight plus weight-related comorbidities, excluding those with diabetes [1]. At 72 weeks, participants receiving tirzepatide 5mg lost an average 15.0% of their baseline body weight, whilst those on the 10mg dose achieved 19.5% reduction and the 15mg cohort reached 20.9% [1]. These results significantly exceeded the 3.1% weight loss observed with placebo.

Importantly, 85% of participants on tirzepatide 5mg achieved at least 5% weight loss — the clinical threshold associated with meaningful health improvements — compared to just 35% in the placebo group [1]. Additionally, 50% of the 5mg cohort lost 15% or more of their body weight, a magnitude previously only achievable through bariatric surgery. The trial also demonstrated improvements in cardiometabolic markers including blood pressure, lipid profiles, and inflammatory markers.

The SURPASS clinical programme, which evaluated tirzepatide in type 2 diabetes populations, provided further evidence of efficacy. SURPASS-2 directly compared tirzepatide against semaglutide 1mg, showing superior HbA1c reduction and weight loss across all tirzepatide doses [2]. These head-to-head results have positioned tirzepatide as the most effective pharmacological option currently available for weight management in the UK.

Real-World Effectiveness

Beyond controlled trial environments, UK prescribers report consistent patient outcomes with Mounjaro 5mg in clinical practice. The medication's once-weekly administration improves adherence compared to daily injection regimens, whilst the gradual dose escalation protocol minimises treatment discontinuation due to side effects. As Superintendent Pharmacist Tarun Kumar (GPhC 2233073) notes, patients who complete the full titration schedule and maintain lifestyle modifications typically achieve weight loss aligned with trial data, subject to individual variation.

Mounjaro 5mg vs Other Weight Loss Treatments

When comparing weight loss medications available through UK pharmacies, understanding the mechanistic and practical differences helps inform treatment selection. Mounjaro's dual receptor agonism distinguishes it from earlier GLP-1 therapies, whilst oral medications like orlistat work through entirely different pathways.

Wegovy contains semaglutide, a GLP-1-only receptor agonist that demonstrated 14.9% average weight loss at the 2.4mg dose in the STEP-1 trial [3]. Whilst highly effective, this represents approximately 5 percentage points less weight reduction than Mounjaro 5mg achieved in head-to-head comparisons. Saxenda uses liraglutide, an earlier-generation GLP-1 medication requiring daily injections, with average weight loss of 8.0% in clinical trials [4].

Orlistat-based treatments work by blocking dietary fat absorption rather than affecting appetite hormones. Clinical trials show average weight loss of 3-5% with orlistat, significantly less than injectable GLP-1 therapies but with a different side effect profile [5]. The choice between these options depends on your medical history, weight loss goals, injection preference, and cost considerations — factors your UK prescriber will assess during consultation.

Choosing Your Treatment Pathway

Administration involves subcutaneous injection into the abdomen, thigh, or upper arm once weekly, on the same day each week. The KwikPen device features an automatic needle insertion mechanism and dose counter, making self-administration straightforward even for injection-naive patients. After removing the pen from refrigeration, allow it to reach room temperature for 30 minutes before injecting. Rotate injection sites weekly to prevent lipohypertrophy. For the cheapest buy Mounjaro 5mg single pen UK online with full support, Cured Pharmacy's clinical team is available throughout your treatment.

Dosing Schedule and Pen Administration

The Mounjaro 5mg single pen contains four weekly doses of 5mg tirzepatide in a pre-filled KwikPen device. Standard UK prescribing protocols begin with 2.5mg weekly for four weeks, then escalate to 5mg weekly for at least four weeks before considering further dose increases [6]. This gradual titration minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's metabolic effects.

Administration involves subcutaneous injection into the abdomen, thigh, or upper arm once weekly, on the same day each week. The KwikPen device features an automatic needle insertion mechanism and dose counter, making self-administration straightforward even for injection-naive patients. After removing the pen from refrigeration, allow it to reach room temperature for 30 minutes before injecting. Rotate injection sites weekly to prevent lipohypertrophy.

If you miss a dose and fewer than four days have passed, inject as soon as you remember and continue your regular schedule. If more than four days have elapsed, skip the missed dose and resume with your next scheduled injection. Never double doses to compensate for missed administrations. Your prescriber will provide detailed injection technique instructions, and Cured Pharmacy's clinical team remains available for administration queries throughout your treatment.

Side Effects and Safety Considerations

The most common side effects of Mounjaro 5mg are gastrointestinal, including nausea (reported by 25-30% of trial participants), diarrhoea, constipation, vomiting, and abdominal discomfort [1]. These effects typically emerge during dose escalation and diminish over 4-8 weeks as your body adapts. Starting at 2.5mg and gradually increasing to 5mg significantly reduces the severity and duration of these symptoms.

Purchasing the cheapest buy Mounjaro 5mg single pen UK online through Cured Pharmacy begins with a free online clinical consultation taking under three minutes to complete. You'll provide medical history details including current medications, previous weight loss attempts, and relevant health conditions. A UK-registered prescriber reviews your assessment within hours, and if clinically appropriate, issues a prescription processed by our GPhC-registered pharmacy (registration number 9012511).

During your clinical assessment, your UK prescriber will review your full medical history to identify contraindications. Mounjaro is not suitable during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception during treatment. If you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction, discontinue use and seek immediate medical attention. All side effects should be reported to your prescriber and can be logged via the MHRA Yellow Card Scheme.

Managing Common Side Effects

To minimise nausea, eat smaller, more frequent meals and avoid high-fat foods during the first weeks of treatment. Stay well-hydrated, particularly if experiencing diarrhoea or vomiting. Anti-nausea medications such as domperidone may be prescribed if symptoms persist beyond the initial adaptation period. Most patients find gastrointestinal effects resolve substantially by week 8 at the 5mg dose, allowing comfortable continuation of therapy.

Ordering Cheapest Buy Mounjaro 5mg Single Pen UK Online from Cured Pharmacy

Purchasing Mounjaro through Cured Pharmacy begins with a free online clinical consultation taking under three minutes to complete. You'll provide medical history details including current medications, previous weight loss attempts, and relevant health conditions. A UK-registered prescriber reviews your assessment within hours, and if clinically appropriate, issues a prescription processed by our GPhC-registered pharmacy (registration number 9012511).

We guarantee the lowest prices in the UK for genuine, MHRA-licensed medications. The Mounjaro 5mg single pen is priced at £124.99, with transparent costs displayed before you begin your consultation — no hidden fees or surprise charges at checkout. All medications are sourced directly from UK-licensed wholesalers and stored in temperature-controlled facilities meeting MHRA standards.

Orders placed before 3pm Monday to Friday are dispatched the same day via Royal Mail Tracked 24 service in discreet, unmarked packaging. Your medication arrives with full patient information leaflets, injection technique guides, and access to our clinical support team. Repeat prescriptions can be scheduled through your online account, with automatic reminders ensuring you never miss a dose. As a UK-registered pharmacy under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), we maintain the highest standards of pharmaceutical care and regulatory compliance.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Yanovski, S. Z., & Yanovski, J. A. (2014). Long-term Drug Treatment for Obesity: A Systematic and Clinical Review. JAMA, 311(1), 74–86. https://doi.org/10.1001/jama.2013.281361 [accessed 13 August 2026]
6. Electronic Medicines Compendium. (2023). Mounjaro 5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Medicines.org.uk. Retrieved from https://www.medicines.org.uk/emc/product/14270 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are not guaranteed.